Brain Stimulation for Dyslexia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether transcranial magnetic stimulation (TMS) can influence how older youth learn and remember new words. TMS is a non-invasive method that uses magnetic fields to stimulate the brain. The study compares the effects of real and sham (fake) stimulation on word learning. Ideal participants are native English speakers with normal or corrected vision who do not have autism, certain hearing or vision deficits, or metal in their body. As an unphased trial, this study allows participants to contribute to groundbreaking research in cognitive science.
Will I have to stop taking my current medications?
The trial excludes individuals taking certain medications that lower the seizure threshold, so you may need to stop taking those specific medications. The protocol does not specify other medication restrictions.
What prior data suggests that transcranial magnetic stimulation is safe for older youth?
Research has shown that transcranial magnetic stimulation (TMS) affects reading and dyslexia by targeting specific brain areas. For example, studies have demonstrated that TMS can explore questions about dyslexia without significant safety concerns.
Regarding safety, TMS typically causes only minor side effects. In one study with ADHD patients, TMS improved symptoms with only minor side effects reported. Additionally, any discomfort from TMS usually resolves quickly.
Overall, TMS appears well-tolerated with minor side effects in these studies, suggesting a similar level of safety might be expected in trials exploring TMS for dyslexia.12345Why are researchers excited about this trial?
Unlike traditional dyslexia treatments, which often focus on educational interventions and supportive therapies, transcranial magnetic stimulation (TMS) offers a novel approach by directly targeting the brain's neural activity. This treatment is unique because it uses magnetic fields to stimulate the left supramarginal gyrus, a brain area linked with language processing, potentially reshaping neural pathways to improve reading skills. Researchers are excited about TMS because it could provide a non-invasive, quick-acting alternative with the potential for lasting effects, bypassing the lengthy and sometimes limited impact of conventional methods.
What evidence suggests that transcranial magnetic stimulation is effective for dyslexia?
Studies have shown that Transcranial Magnetic Stimulation (TMS) can impact reading skills. Specifically, applying TMS to brain areas involved in reading leads to faster reading of pseudowords, which are made-up words that follow normal spelling rules. Research indicates that TMS in certain brain areas also improves reading accuracy for these non-words. In this trial, participants will receive either active cTBS or sham stimulation to the left supramarginal gyrus. These findings suggest that TMS could be a promising method to address reading difficulties like dyslexia by altering how the brain processes written language.12678
Are You a Good Fit for This Trial?
This trial is for older youth with dyslexia. Participants should be able to undergo brain stimulation and are interested in how it might affect learning new spoken words. Specific eligibility details aren't provided, so generally healthy individuals who meet the age requirement for 'older youth' may apply.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline MRI
Participants complete a baseline MRI session to assess the reading and language network
Treatment
Participants receive cTBS or sham stimulation followed by pseudoword discrimination and word learning tasks
Follow-up
Participants are monitored for retention of learned items 24 hours after each treatment session
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation is already approved in United States, Canada, European Union for the following indications:
- Major Depressive Disorder
- Obsessive Compulsive Disorder
- Major Depressive Disorder
- Major Depressive Disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgia State University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator